Genghis Lloyd-Harris

Partner · Abingworth

Decision maker

Email

Verified, deliverable email

Unlock Genghis and the rest of Abingworth

One payment, no subscription - every verified contact at Abingworth drops into your wallet.

Partner at Abingworth

Stages: Series A
Sectors: Health tech
Cheque size: €13.8M–€27.6M
Freshness: Verified today
Fund size: $465M

Notable investments

NouscomSeries B · $49M · 2017
GenSight BiologicsSeries B · $36M · 2015
Wilson TherapeuticsSeries B · $40M · 2014
SyntaxinSeries C · $29M · 2010
Synosia TherapeuticsSeries B · $29M · 2009

Frequently co-invests with

Guido MagniVersant Ventures2×Bali MuralidharAbingworthDeborah HarlandSR OneHakan Goker (M Ventures (Merck))Heath LukatchRed Tree Venture CapitalJoachim RotheEQT Life SciencesMarten SteenHealthCapRené KuijtenEQT Life SciencesScott Rocklage5am VenturesSofia IoannidouAndera Partners

Genghis Lloyd-Harris's colleagues at Abingworth

Every verified colleague at Abingworth

One payment, no subscription - they all drop into your wallet.

Andrew SinclairPartner, Abingworth

Kurt von EmsterManaging Partner, Abingworth

Jacqueline GrantPrincipal, Abingworth

See all 4 at Abingworth →

Related lists

Health tech investors

Similar investors

Prachi SinhaInvestor, Axilor Ventures

Blake PateAnalyst, Bios Partners

Przemek OblojManaging Partner, Blue Horizon

Raffi KamberGeneral Partner, Singular

Quan ZhouManaging Partner, IDG Capital

Pierre SochaPartner, Amadeus Capital Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Genghis Lloyd-Harris? Request removal of this listing.